Health Policy

Restoring pre-transplant waiting time for deceased-donor kidney recipients with allograft failure within 1 year of transplant may benefit the kidney waitlist through decrease in proportion of deceased-donor kidneys discarded.

David A. Eagle, MD, will join New York Cancer & Blood Specialists on Oct. 15.

A project that restructured primary care health professional shortage area designations could improve the distribution of primary care clinicians and resources in the United States, according to a recent analysis in JAMA Network Open.

A COVID-19 vaccination model demonstrated that achieving 50% coverage by the summer could prevent almost 6 million additional cases in the United States compared with achieving that milestone in the fall, researchers reported.

The U.S. public health community was unable to foresee the rampant politicization of the COVID-19 pandemic, and was shocked by the initial federal response, according to New York Times bestselling author John M. Barry.

Rachel Solnick, MD, MSc, is an emergency medicine physician and health services researcher. In this episode, we discuss her journey into public policy, how to navigate misinformation on social media and why doctors should be policy advocates.

Kristin Ferguson, DNP, RN, OCN, has been appointed senior director of cancer care delivery and health policy for Association of Community Cancer Centers.

Stigma and potential career consequences may prevent ED physicians from seeking mental health care, according to poll data discussed during an American College of Emergency Physicians’ teleconference.

In addition to helping their own patients with medical care, physicians can create widespread change through health care policy advocacy, according to a presentation at the virtual Women in Medicine Summit.

Anita Gupta, DO, PharmD, MPP, GMP, FASA, is a member of Healio Primary Care's Peer Perspective Board. She is adjunct assistant professor of anesthesiology and pain medicine at Johns Hopkins School of Medicine. She is also an expert in health policy, biotechnology, drug development and corporate and government affairs.